Article thumbnail

Gene Expression Profiles in Stage I Uterine Serous Carcinoma in Comparison to Grade 3 and Grade 1 Stage I Endometrioid Adenocarcinoma

By Paulette Mhawech-Fauceglia, Dan Wang, Joshua Kesterson, Susanna Syriac, Kimberly Clark, Peter J. Frederick, Shashikant Lele and Song Liu
Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2008). A genome-wide gene expression signature of environmental geography in leukocytes of Moroccan Amazighs.
  2. (2008). Activated leukocyte cell adhesion molecule: a new paradox in cancer.
  3. (2010). ALCAM is associated with chemoresistance and tumor cell adhesion in pancreatic cancer.
  4. (2010). ALCAM, Activated leukocyte cell adhesion molecule, influences the aggressive nature of breast cancer cells, a potential connection to bone metastasis.
  5. (2004). Bioconductor: open software development for computational biology and bioinformatics.
  6. (2009). Cancer Satistics.
  7. (2010). Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma.
  8. (2010). Clinical Practice Guidelines in Oncology.
  9. (2007). Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: Similar outcomes belie distinctive biologic differences.
  10. (1998). Cluster analysis and display of genome-wide expression patterns.
  11. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing.
  12. (2007). DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists.
  13. (2004). Dual role of carcinoembryonic antigen-related cell adhesion molecule 1 in angiogenesis and invasion of human urinary bladder cancer.
  14. (2009). Endometrial Cancer Working Group of the Gynecoloic Cancer Intergroup
  15. (2000). ERM proteins: From cellular architecture to cell signaling.
  16. (2009). Expression of c–synuclein in colorectal cancer tissues and its role on colorectal cancer cell line HCT116.
  17. (2002). Ezrin, a membrane-cytoskeletal linking protein, is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma.
  18. (1999). Ezrin, a membrane-cytoskeletal linking protein, is involved in the process of invasion of endometrial cancer cells.
  19. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
  20. (2008). Genes involved in differentiation, stem cell renewal, and tumorigenesis are modulated in telomerase-immortalized human urothelial cells.
  21. (1997). Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing.
  22. (2002). Is there a difference in outcome between stage I-II endometrial cancer of papillary Gene Expression Pattern in
  23. (2008). Lamin A: a putative colonic epithelial stem cell biomarker which identifies colorectal tumours with a more aggressive phenotype.
  24. (2008). Lamin A/C is a risk biomarker in colorectal cancer.
  25. (2004). Linear models and empirical Bayes methods for assessing differential expression in microarray experiments.
  26. (2005). Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers.
  27. (2008). Lumina pipeline for processing Illumina microarray.
  28. (2010). Moesin/ezrin: a specific role in cell metastasis?
  29. (2010). Moesindependent cytoskeleton remodelling is associated with an anaplastic phenotype of pancreatic cancer.
  30. (2004). Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium.
  31. (2009). Pure papillary serous tumors of the endometrium. A clinicopathological analysis of 61 cases from a single institution.
  32. (1999). Stimulation of breast cancer invasion and metastasis by synuclein gamma.
  33. (2008). Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients.
  34. (2009). Synuclein-c (SNCG) may be a novel prognostic biomarker in uterine papillary serous carcinoma.
  35. (2006). The laminopathies: the functional architecture of the nucleus and its contribution to disease.
  36. (2000). The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
  37. (2009). The roles of cell adhesion molecules in tumor suppression and cell migration: a new paradox.
  38. (2008). Uterine papillary serous carcinoma state of the state.